Over the last 90 days, Medipharm Labs Corp. has seen one insider transaction, a sell totaling CAD 13,258.95 by Director Christopher David Taves. This follows previous sell transactions by Directors Keith Strachan and Gregory Edison Hunter in June and August 2023. The stock has experienced a 15.4% price increase over the past 90 days.